Fenofibrate Capsule
Product Images NDC 62559-461

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 62559-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150-label (150 Label)

150-label (150 Label)
This is a description of a medication called Fenofibrate. It comes in capsule form with a strength of 150mg and is available only through prescription. Each capsule contains the active ingredient Fenofibrate USP. It is typically taken as directed in the package insert. The medication must be stored at a temperature of 25°C with excursions allowed between 15° to 30°C. Fenofibrate should be protected from moisture and light, and kept out of the reach of children. It is distributed by ANI Pharmaceuticals, Inc. and is a product of Israel. Additional information about the medication is provided on the package.*
FDA Label Image

50-label (50 Label)

50-label (50 Label)
This is a description of a medication labeled as NDC 62559-460-90. Each capsule contains 50mg of Fenofibrate USP. The recommended dosage can be found in the package insert along with full prescribing information. The medication should be stored at 25°C with excursions permitted. It should be protected from moisture and light. The label advises to keep the medication out of the reach of children. The product originates from Israel and is distributed by ANI Pharmaceuticals, Inc. *
FDA Label Image

Fenofibrate 01

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.